Purification of Biotransformation Products of Cis-Isoflavan-4-Ol by Biphenyl Dioxygenase of Pseudomonas pseudoalcaligenes Kf707 Strain Expressed in Escherichia coli by Sulistiyani, Tri Ratna & Budiyanto, Agus
Sulistiyani dan Budiyanto, Purification of Biotransformation Products of Cis : 53-59
Purification of Biotransformation Products of Cis-Isoflavan-4-Ol by Biphenyl
Dioxygenase of Pseudomonas pseudoalcaligenes Kf707 Strain Expressed
in Escherichia coli
Tri Ratna Sulistiyani1) and Agus Budiyanto2)
1)Research Center for Biology, Indonesian Institute of Sciences, Cibinong Science Center,
Indonesia.
2)Indonesian Center for Agricultural Postharvest Research and Development
e-mail address: tri_ratna83@yahoo.com
Abstract
Isoflavone has multiple beneficial  effects on human health,  especially as antioxidant and
anticancer. Biotransformation of two enantiomers (CE1 and CE2) of cis-isoflavan-4-ol by  E. coli
JM109  (pJHF108)  carrying  a  biphenyl  dioxygenase  gene  from  P.  pseudoalcaligenes KF707
produced two products and they were designated as CM1 and CM2. They had retention time at
11.9 and 14.6 min, respectively, and same absorption peaks at 204, 220 and 275 nm. CM1 and
CM2 had [M-H2O+H]+  at m/z 225. Based on the molecular mass, hydrolysis products, and previous
report, this study proposed that epoxidation occurred on  cis-isoflavan-4-ol. Chloroform extraction
was done to improve the stability of CM1 and CM2.
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Introduction
Flavonoids are commonly divided into six subgroups, and classified based on the
connection position of the B and C rings as well as the degree of saturation, oxidation,
and  hydroxylation  of  the  C  ring,  as  flavonols,  flavones,  flavanones,  flavan-3-ols  (or
catechins),  isoflavones,  and  anthocyanidins  (Graf  et  al.,  2005).  It  has  characteristic
structure  and  contains  a  rearranged  C15  skeleton  based  on  3-phenylchromen-4-one
(Akashi et al., 1999; Schantz,  2001).
Interestingly,  isoflavones  posses  several  biological  and  physiological  properties
including  antioxidant,  anti  cancer  especially  hormone-dependent  breast  and  prostate
cancers, and in chemotaxis of nitrogen fixing bacteria (Dixon and Steele, 1999; Seeger et
al.,  2003;  Han  et  al., 2005;  Miyazawa,  2006;  Won  et  al., 2008).  Isoflavones  are
phytoestrogents  which  structurally  similar  with  genuine  17-  estradiol  and  have  weak
estrogenic activities, therefore they can modulate the actions of endogenous estrogens in
vertebrates  by  binding  to  estrogen  receptor  (ERs)  (Bayer  et  al., 2001;  Hodex,  2002;
Erdman, 2005; Zhang, 2007).
To extend the diversity  of  flavonoids and to improve biological  and physiological
properties,  chemical  synthesis  is  being  used,  for  example  by  reduction  with  catalyst
palladium  on  activated  carbon  (Pd/C)  and  ammonium  formate  under  N2 atmosphere
(Seunaga  et  al.,  2002).  However, chemical  synthesis  generally  generates  toxic  waste
products (Erdman, 2005). Microbial transformation offers the advantages of cost-effective,
high value organic molecular, and reduce levels of toxic waste products (Seeger  et al.,
2003;  Miyazawa,  2006).  Biotransformation  with  recombinant  microbial  enzymes  and
biomolecular engineering has been widely used, including application for the production of
hormones, antibiotics, and chemicals (Seeger et al., 2003). Therefore, we tried to produce
isoflavone derivatives using microbial transformation.
Polychlorinated biphenyls  (PCBs)  is  one example of  environmental  contaminants
which have multiple effects to disrupt hormonal system both in animal and human, and is
commonly known as endocrine disrupting chemicals (EDCs) (Schantz et al., 2001;  Ang et
al., 2005). Bioremediation may be an alternative way to restore contaminated environment
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from persistent organic pollutants (POPs). Biphenyl-degrading bacteria are one example
which able to degrade PCBs. Biphenyl dioxygenase (BDO) is key enzyme of catabolic
pathway  which  is  involved  in  degradation  of  PCBs.  It  is  responsible  for  the  initial
dioxygenation step during metabolism of biphenyl, and consisting of terminal dioxygenase,
ferredoxin, and ferredoxin reductase (Figure 1) (Dixon  et al., 1999; Seeger  et al., 2003;
Alawiyah et al., 2007; Romsaiyud et al., 2008). Due to the similarity chemical structure of
isoflavone  and  biphenyl,  we  assumed  that  isoflavones  are  substrate  for  biphenyl
dioxygenase. 
Alawiyah et al. (2007) and Romsaiyud et al. (2007) reported that biotransformation
of isoflavan-4-ol by BDO resulted in four epoxidation or hydroxylation metabolites such as
CM1, CM2, TM1, and TM2. In this study, we tried to purify CM1 and CM2 and to modify
extraction method to solve degradation problem during product purification.
Figure 1. Dioxygenation of biphenyl by BDO P. psedoalcaligenes KF707.
Material and methods
Microorganism,  culture  condition  and  preparation  of  resting  cells. E.  coli JM109
(pJHF108) carrying a BDO gene from P. pseudoalcaligenes KF707 was kindly provided by
Professor K. Furukawa at Kyushu University, Japan. Fermentor culture, subculture was
grown in LB medium pH 7.2 and 50 μg/mL of ampicillin and carried out at 37oC for 12 hrs
reciprocal shaker 200 rpm. The culture was poured to the 5 L fermentor containing 4.5 L
LB medium and 50 μg/mL of ampicillin. The fermentor was constantly aerated and stirred
at 250 rpm, 37 °C for 8 hrs. After 8 hrs, cultures were harvested and centrifuged at 7000
rpm, 4oC, for 10 min. The harvested cells were washed three times with MSB buffer (1 X)
and suspended in 1 X MSB buffer. Cells suspension was used for the biotransformation
reaction.
Production of isoflavan-4-ols. Palladium on activated carbon (50 mg) was added to
suspension isoflavone (100 mg, 0.90 mmol) in anhydrous ethanol (20 mL) together with
ammonium  formate  (200  mg,  6.53  mmol).  The  reaction  mixture  was  stirred  at  room
temperature for 24 hrs under nitrogen atmosphere. The catalyst was removed by filtration
and  filtrate  was  concentrated  under  reduced  pressure.  The  residue  was  dissolved  in
chloroform (50 mL), washed with water two times and dried over anhydrous MgSO4. The
product was isolated using preparative layer chromatography (PLC) (100% CHCl3). 
Purification of enantiomers of cis-isoflavan-4-ol. To purify each enantiomer of  cis-
isoflavan-4-ol (CE1 and CE2), chiral column chromatography was carried out. The column
was a  Sumi  Chiral  OA-7000 column   (5  m particle  size,  20 mm x  25 cm;  Sumika
Chemical Analysis Service, Ltd., Osaka, Japan) and the mobile phase consisted of 20 mM
phosphate buffer pH 3.0 and acetonitrile (70 : 30, v/v). Flow rate was 18 ml/min and UV
detection was done at 270 nm.
Biotransformation kinetics  of  enantiomers  of  cis-isoflavan-4-ol  by  BDO. To study
biotransformation kinetics of CE1 and CE2, resting cells of  E. coli ( OD 600 = 10) was
mixed with CE1 or CE2 and glucose at final concentration 0.1 mM and 1 M, respectively,
and incubated at 37oC with reciprocal shaker 200 rpm and samples were analyzed every 2
hrs during incubation time. To analyze metabolite, the reaction solution was centrifuged
and supernatant extracted with three volume ethyl acetate. The ethyl acetate layer was
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filtered on sodium sulfate and concentrated using rotary evaporator. The residue was
dissolved in methanol and followed by filter using PVDF syringe filters and analyzed by
HPLC.  In the modified  extraction method,  culture supernatant  was extracted with one
volume of chloroform five times. 
Purification of CM1 and CM2. To purify CM1 and CM2, HPLC Varian Prostar (Walnut
Creek, CA) with a Waters Spherisorb® ODS-2 C18 column (5 m particle size, 4.6 mm x
250 mm) was used. Flow rate was 18 mL/min and detection was done at 270 nm. The
mobile  phase  consisted  of  water  (solvent  A)  and  acetonitrile  (solvent  B).  The  elution
program was performed: 10% solvent B at 0 min, 40 % solvent B for 20 min, 90% solvent
B for 15 min.
High performance liquid chromatography (HPLC). Biotransformation products of cis-
isoflavan-4-ol was analyzed using HPLC Varian Prostar (Walnut Creek, CA) equipped with
a Waters Spherisorb® ODS-2 C18 column (5 m particle size, 4.6 mm x 250 mm). Flow
rate was maintained at 1 mL/min and the detection was done at 270 nm. The mobile
phase consisted of water containing 0.1 % formic acid (solvent A) and acetonitrile (solvent
B). The elution program was as follows: 10% solvent B at 0 min, 40 % solvent B for 15
min, 90% solvent B for 10 min, and by 10 min equilibrium.
Liquid chromatography/ mass spectrophotometry (LC/MS). LC/MS was carried out
by  coupling  Alliance  2695  (Waters  Corporation,  Miford,  MA)  with  a  Quattro  LC
triplequadruple tandem mass spectrometer) Waters Corporation, Miford, MA) in positive
electrospray ionization (ESI+) mode. The mobile phase and elution program were same
as analytical HPLC and flow rate was 0.2 mL/min and UV detection was performed with
photo diode array detector 2996 (Waters Corporation, Miford, MA). Injection volume was
10  µL.  The  source  temperature,  desolvation  temperature,  cone  voltage  and  capillary
voltage, and electron multiplier voltage, were set at 150oC, 350oC, 25 V and 3.0 kV, and
700 V, respectively. Nitrogen gas was used for cone gas and set at 30 L/h and ultra pure
nitrogen gas was used for desolvation gas and set at 500 L/h.
Result and Discussion
Production of isoflavan-4-ols. To produce  cis-isoflavan-4-ol, reduction of isoflavone
was  carried  out  using  catalyst  palladium  on  activated  carbon  (Pd/C)  and  ammonium
formate. Two isoflavan-4-ol stereoisomers appeared as products (Figure 2).  Confirmed
with NMR data, they were  cis-isoflavan-4-ol and  trans-isoflavan-4-ol,  respectively (data
not shown). They were separated by thin layer chromatography and each stereoisomer
fraction was almost pure (Figure 3B and 3C).
Figure 2. HPLC  chromatogram  of  cis-  and  trans-isoflavan-4-ol.  (A)  Products  from
chemical reduction of isoflavone, (B)  Cis-isoflavan-4-ol after purification with
preparative  TLC,(C)  Trans-isoflavan-4-ol  after  purification  with  preparative
TLC.  .  
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Purification  of  enantiomers  of  cis-isoflavan-4-ol. Enantiomers  of  cis-isoflavan-4-ol
were purified by a preparative HPLC using chiral column. Each enantiomer was designed
as CE1 and CE2 (Figure 3). Recently, the absolute configuration of CE1 and CE2 was
determined  as  (3R,  4R)-cis-isoflavan-4-ol  and  (3S,  4S)-cis-isoflavan-4-ol,  respectively
(Won et al., 2008).
Figure 3. Separation of  cis-isoflavan-4-ol enantiomers by chiral column chromatography
Biotransformation of CE1 and CE2 by BDO  . Two enantiomers of  cis-isoflavan-4-ol
(CE1 and CE2) were used as a substrate for the biotransformation by BDO. Purified CE1
and CE2 were incubated with BDO and the product of CE1 and CE2 were assigned as
CM2 and CM1, respectively (Figure 4).
Figure 4. HPLC chromatograms of biotransformation products produced from CE2 (A) and
CE1 (B) by BDO. Blue line: 0 hr; Red line: 12 hr.
(A)
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(B)
Figure 5. Biotransformation kinetics of CE1 (A) and CE2 (B) by BDO
According to HPLC analysis, CM1 and CM2 showed retention time at 11. 9 and 14.6
min and they had the same absorption peaks at 204, 220 and 275 nm, respectively. The
biotransformation kinetics was studied for CE1 and CE2, it showed that the concentration
of CM2 increased and until 12 hrs and almost all of CE1 was transformed to CM2 (Figure
5A). In case of CE2, maximal activity was obtained within 8 hrs and only 30 % of CE2
transformed to CM1 ( Figure 5B).
Purification of CM1 and CM2  . CM1 and CM2 were purified from reaction solution by
preparative  HPLC  using  C18  column.  The  fraction  containing  CM1  and  CM2  were
extracted with ethyl acetate and evaporated. The residue was dissolved in methanol and
analyzed by HPLC. Unfortunately, the final fraction contained two other more hydrophobic
products (HP1 and HP2). 
Figure 6. LC/MS spectra of CM1, CM2 and HP2.
To find differences among original products (CM1 and CM2) and hydrolysis products
(HP1 and HP2), they were analyzed with LC/MS. All of them have same [M-H2O+H]+  at
m/z 225 (Figure 6) and also showed same UV spectra. We thought that HP1 and HP2
were produced from CM1 and CM2 by acidic hydrolysis (ring opening). Han  et al. 2005
reported  that  biotransformation  product  of  flavanone  by  BDO  produced  an  epoxide
functional group on the metabolites. Therefore, we proposed that CM1 and CM2 might be
epoxide  product  of  CE1  and  CE2,  respectively,  and  HP1  and  HP2  are  hydroxylated
products of CE1 and CE2, respectively.
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To solve the hydroxylated products, during evaporation, we tried to modify extraction
solvent and scheme. Instead of ethyl acetate, chloroform was used as extraction solvent.
One volume of chloroform was added to the reaction solution and even after five times
extraction,  still  a little of CM1 was left  (data not shown). Therefore we concluded that
chloroform extract should be done at least five times. We removed ethyl acetate extraction
step  for  the  preparative  HPLC  fractions  and  included  evaporation  step  to  remove
acetonitrile  from  HPLC  fraction  and  freeze  drying  step.  We  also  included  hexane
extraction step before chloroform extraction.
Conclusion
Cis-isoflavanol  was produced from isoflavone by chemical  reduction method and
each enantiomer (CE1 and CE2) were purified by preparative HPLC.  E. coli expressing
biphenyl dioxygenase transformed CE1 and CE2 to CM2 and CM1, respectively. During
ethyl  acetate  extraction  and evaporation  step following  preparative  HPLC,  non-  target
products (HP1 and HP2) were produced. We modified extraction step using chloroform
instead of ethyl acetate. Based on the molecular mass, hydrolysis products, and previous
result  [9],  we proposed that  CM1 and CM2 are epoxidized product  of  CE2 and CE1,
respectively.  Furthermore,  purification  of  CM1  and  CM2  will  be  done  by  modified
procedure and structure of CM1 and CM2 will be determined by NMR.
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